Skip to content
EvidenceHelixEvidenceLib · Scientific Encyclopedia
⌘ K

Scientific library

EvidenceLib encyclopediaAll articles A–Z2,100Open textbooks2Cancer study catalog458How it is made

My workspace this browser

Saved pages0Notes & annotations0

Recently viewed

Explore by field

Cancer and Oncology107Genetics and Genomics95Neuroscience110Cardiovascular Medicine105Immunology90Pharmacology99Molecular Biology100Infectious Diseases102Rare and Inherited Diseases106Clinical Research98Anatomy and Physiology542Drugs and Chemicals546
Plans & pricingCompare EvidenceHelix workspace plans
Library›EvidenceLib›Drugs and Chemicals›Ethanolamine
Explore more with EvidenceHelix Workspace

Compare studies, analyze evidence and create research reports with premium tools.

Explore Researcher plans

Research reading room

Ethanolamine

Drugs and Chemicals · NLM MeSH · updated 2026-10-31 · version 1

Citations verified against PubMedNot yet clinician-reviewed10 referencesApproximately 4 min read

A viscous, hygroscopic amino alcohol with an ammoniacal odor.

Table of Contents

1. Definition2. Research landscape3. Reading the evidence4. Open-access studies5. Key reviews6. References7. About this article

Definition and research guide

This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.

Content available: 4 complete abstracts (669 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.

Definition

A viscous, hygroscopic amino alcohol with an ammoniacal odor. It is widely distributed in biological tissue and is a component of lecithin. It is used as a surfactant, fluorimetric reagent, and to remove CO2 and H2S from natural gas and other gases.

Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.

Also known as: 2-Aminoethanol; 2 Aminoethanol; Colamine; Monoethanolamine.

Where it fits in the MeSH classification

Broader topics
Ethanolamines

Research landscape

PubMed indexes 1,302 records tagged with the MeSH heading “Ethanolamine” (counts retrieved 2026-10-31). 175 of them (13.4%) were published from 2020 onward, and the busiest period so far is through 1999 with 605 records.

Reviews account for 40 records (3.1%) and meta-analyses for 1. Randomized controlled trials number 12 (0.9%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.

PubMed records by publication periodthrough 1999: 605 records; 2000-2009: 219 records; 2010-2019: 303 records; 2020 onward: 175 records605through 19992192000-20093032010-20191752020 onward
Records in PubMed indexed with this heading, by publication period. Real counts from NCBI E-utilities; the final period covers only part of the current year. Volume reflects how much has been published, not how strong the evidence is.
Show the data
PeriodRecords
through 1999605
2000-2009219
2010-2019303
2020 onward175
Share of records by publication typeReviews: 3.1 percent; Meta-analyses: 0.1 percent; Randomized controlled trials: 0.9 percentReviews3.1% (40)Meta-analyses0.1% (1)Randomized controlled trials0.9% (12)
Share of all PubMed records on this heading that carry each publication type. Types overlap with other records, so the shares do not sum to 100%.
Publication-type chart data
Publication types among 1,302 PubMed records
TypeRecordsShare
Reviews403.1%
Meta-analyses10.1%
Randomized controlled trials120.9%

Method: PubMed query "Ethanolamine"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.

Reading the evidence in drugs and chemicals

Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.

Evidence from open-access studies

These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.

Study comparison — selected abstracts, not a systematic review
Study / authorsYearSource label / designEurope PMC citationsLicence / source
Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease
Patel D, Witt SN
2017Review article
Design not recorded in structured metadata
298cc by
PMID 28785375 · DOI · PMC5529665
Ethanolamine Utilization in Bacteria
Kaval KG, Garsin DA
2018Review article
Design not recorded in structured metadata
122cc by
PMID 29463652 · DOI · PMC5821096
Ethanolamine Signaling Promotes Salmonella Niche Recognition and Adaptation during Infection
Anderson CJ, Clark DE, Adli M, Kendall MM
2015Research article
Design not recorded in structured metadata
84cc by
PMID 26565973 · DOI · PMC4643982
Metabolic Labeling of Phosphatidylethanolamine Lipids in Cells Using Clickable Ethanolamine Analogs
Maraski RJ, Lou J, Reynolds TB, Best MD
2026Research article
Design not recorded in structured metadata
1cc by
PMID 42599685 · DOI · PMC13475593

Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease [1]

Review article Patel D, Witt SN · · 2017 · cited 298 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Phosphatidylethanolamine (PE) is the second most abundant phospholipid in mammalian cells.
Closing excerpt
In this review, we focus on PE's roles in lipid-induced stress in the endoplasmic reticulum (ER), Parkinson's disease (PD), ferroptosis, and cancer.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (105 words)

Phosphatidylethanolamine (PE) is the second most abundant phospholipid in mammalian cells. PE comprises about 15-25% of the total lipid in mammalian cells; it is enriched in the inner leaflet of membranes, and it is especially abundant in the inner mitochondrial membrane. PE has quite remarkable activities: it is a lipid chaperone that assists in the folding of certain membrane proteins, it is required for the activity of several of the respiratory complexes, and it plays a key role in the initiation of autophagy. In this review, we focus on PE's roles in lipid-induced stress in the endoplasmic reticulum (ER), Parkinson's disease (PD), ferroptosis, and cancer.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 28785375 · DOI · PMC5529665

Ethanolamine Utilization in Bacteria [2]

Review article Kaval KG, Garsin DA · · 2018 · cited 122 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Ethanolamine (EA) is a valuable source of carbon and/or nitrogen for bacteria capable of its catabolism.
Closing excerpt
In addition to providing an overview of EA-related biology, this minireview will give special attention to these recent advances.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (223 words)

Ethanolamine (EA) is a valuable source of carbon and/or nitrogen for bacteria capable of its catabolism. Because it is derived from the membrane phospholipid phosphatidylethanolamine, it is particularly prevalent in the gastrointestinal tract, which is membrane rich due to turnover of the intestinal epithelium and the resident microbiota. Intriguingly, many gut pathogens carry the eut (ethanolamine utilization) genes. EA utilization has been studied for about 50 years, with most of the early work occurring in just a couple of species of Enterobacteriaceae Once the metabolic pathways and enzymes were characterized by biochemical approaches, genetic screens were used to map the various activities to the eut genes. With the rise of genomics, the diversity of bacteria containing the eut genes and surprising differences in eut gene content were recognized. Some species contain nearly 20 genes and encode many accessory proteins, while others contain only the core catabolic enzyme. Moreover, the eut genes are regulated by very different mechanisms, depending on the organism and the eut regulator encoded. In the last several years, exciting progress has been made in elucidating the complex regulatory mechanisms that govern eut gene expression. Furthermore, a new appreciation for how EA contributes to infection and colonization in the host is emerging. In addition to providing an overview of EA-related biology, this minireview will give special attention to these recent advances.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29463652 · DOI · PMC5821096

Ethanolamine Signaling Promotes Salmonella Niche Recognition and Adaptation during Infection [3]

Research article Anderson CJ, Clark DE, Adli M, Kendall MM · · 2015 · cited 84 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Chemical and nutrient signaling are fundamental for all cellular processes, including interactions between the mammalian host and the microbiota, which have a significant impact on health and disease.
Closing excerpt
Because the ability to sense ethanolamine is a conserved trait among pathogenic and commensal bacteria, our work indicates that ethanolamine signaling may be a key step in the localized adaptation of bacteria within their mammalian hosts.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (182 words)

Chemical and nutrient signaling are fundamental for all cellular processes, including interactions between the mammalian host and the microbiota, which have a significant impact on health and disease. Ethanolamine is an essential component of cell membranes and has profound signaling activity within mammalian cells by modulating inflammatory responses and intestinal physiology. Here, we describe a virulence-regulating pathway in which the foodborne pathogen Salmonella enterica serovar Typhimurium (S. Typhimurium) exploits ethanolamine signaling to recognize and adapt to distinct niches within the host. The bacterial transcription factor EutR promotes ethanolamine metabolism in the intestine, which enables S. Typhimurium to establish infection. Subsequently, EutR directly activates expression of the Salmonella pathogenicity island 2 in the intramacrophage environment, and thus augments intramacrophage survival. Moreover, EutR is critical for robust dissemination during mammalian infection. Our findings reveal that S. Typhimurium co-opts ethanolamine as a signal to coordinate metabolism and then virulence. Because the ability to sense ethanolamine is a conserved trait among pathogenic and commensal bacteria, our work indicates that ethanolamine signaling may be a key step in the localized adaptation of bacteria within their mammalian hosts.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 26565973 · DOI · PMC4643982

Metabolic Labeling of Phosphatidylethanolamine Lipids in Cells Using Clickable Ethanolamine Analogs [4]

Research article Maraski RJ, Lou J, Reynolds TB, Best MD · · 2026 · cited 1 times (Europe PMC)

Abstract reading summary — source excerpts
Opening excerpt
Phosphatidylethanolamine (PE) is the second most abundant phospholipid in mammalian cells.
Closing excerpt
This approach provides an invaluable step toward metabolic labeling strategies that will aid in the tracking of PE biosynthesis and trafficking pathways in cells.
Interpretation limits
Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (159 words)

Phosphatidylethanolamine (PE) is the second most abundant phospholipid in mammalian cells. The cone-shaped structure of PE positions this lipid to act as a cornerstone of signaling events, such as those involving protein-protein and lipid-protein interactions, as it has been shown to promote conformational changes in both protein and lipid-based membrane structures. Despite this importance, chemical tools to interrogate the biological activity and trafficking of PE lipids are limited. Herein, we report the development of ethanolamine probes functionalized with clickable tags that are capable of infiltrating native cellular pathways and subsequently producing labeled PE lipids. Derivatization of click-tagged PE products enabled fluorescence microscopy imaging of these lipids in cells. Interrogation of the efficacy of these probes for biological incorporation was conducted using mass spectrometry and thin-layer chromatography analysis to identify various species of tagged PE molecules. This approach provides an invaluable step toward metabolic labeling strategies that will aid in the tracking of PE biosynthesis and trafficking pathways in cells.

Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 42599685 · DOI · PMC13475593

Key reviews and meta-analyses

The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.

  • Research article Ethanolamine utilization in bacterial pathogens: roles and regulation [5]
    Garsin DA · Nat Rev Microbiol · 2010 · cited 273 times (Europe PMC)
  • Research article N-Acylethanolamines and precursor phospholipids - relation to cell injury [6]
    Hansen HS, Moesgaard B, Hansen HH, Petersen G · Chem Phys Lipids · 2000 · cited 168 times (Europe PMC)
  • Research article Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively? [7]
    Schmid HH · Chem Phys Lipids · 2000 · cited 120 times (Europe PMC)
  • Research article Towards commercial scale postcombustion capture of CO2 with monoethanolamine solvent: key considerations for solvent management and environmental impacts [8]
    Reynolds AJ, Verheyen TV, Adeloju SB, Meuleman E, Feron P · Environ Sci Technol · 2012 · cited 64 times (Europe PMC)
  • Research article Ethanolamine Metabolism in the Mammalian Gastrointestinal Tract: Mechanisms, Patterns, and Importance [9]
    Zhou J, Xiong X, Wang K, Zou L, Lv D, Yin Y · Curr Mol Med · 2017 · cited 32 times (Europe PMC)
  • Research article Eut bacterial microcompartments: insights into their function, structure, and bioengineering applications [10]
    Held M, Quin MB, Schmidt-Dannert C · J Mol Microbiol Biotechnol · 2013 · cited 30 times (Europe PMC)

References

  1. Patel D, Witt SN. Ethanolamine and Phosphatidylethanolamine: Partners in Health and Disease. . 2017. PMID 28785375 · DOI · PMC5529665
  2. Kaval KG, Garsin DA. Ethanolamine Utilization in Bacteria. . 2018. PMID 29463652 · DOI · PMC5821096
  3. Anderson CJ, Clark DE, Adli M, Kendall MM. Ethanolamine Signaling Promotes Salmonella Niche Recognition and Adaptation during Infection. . 2015. PMID 26565973 · DOI · PMC4643982
  4. Maraski RJ, Lou J, Reynolds TB, Best MD. Metabolic Labeling of Phosphatidylethanolamine Lipids in Cells Using Clickable Ethanolamine Analogs. . 2026. PMID 42599685 · DOI · PMC13475593
  5. Garsin DA. Ethanolamine utilization in bacterial pathogens: roles and regulation. Nat Rev Microbiol. 2010. PMID 20234377 · DOI · PMC2950637
  6. Hansen HS, Moesgaard B, Hansen HH, Petersen G. N-Acylethanolamines and precursor phospholipids - relation to cell injury. Chem Phys Lipids. 2000. PMID 11106787 · DOI
  7. Schmid HH. Pathways and mechanisms of N-acylethanolamine biosynthesis: can anandamide be generated selectively?. Chem Phys Lipids. 2000. PMID 11106783 · DOI
  8. Reynolds AJ, Verheyen TV, Adeloju SB, Meuleman E, Feron P. Towards commercial scale postcombustion capture of CO2 with monoethanolamine solvent: key considerations for solvent management and environmental impacts. Environ Sci Technol. 2012. PMID 22324566 · DOI
  9. Zhou J, Xiong X, Wang K, Zou L, Lv D, Yin Y. Ethanolamine Metabolism in the Mammalian Gastrointestinal Tract: Mechanisms, Patterns, and Importance. Curr Mol Med. 2017. PMID 28429671 · DOI
  10. Held M, Quin MB, Schmidt-Dannert C. Eut bacterial microcompartments: insights into their function, structure, and bioengineering applications. J Mol Microbiol Biotechnol. 2013. PMID 23920494 · DOI

About this article

Sources
NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
Verification
Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
Review state
automated source verified; no human expert review has been recorded yet.
Version
1, last updated 2026-10-31.

See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.

Evidence strength

EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.

Included with the Researcher plan

Reading every article stays free. This computed view is part of the paid plans.

See plans Sign in

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.

Related research topics

  • AlbuterolDrugs and Chemicals
  • AtenololDrugs and Chemicals
  • CarvedilolDrugs and Chemicals
  • CholineDrugs and Chemicals
  • EphedrineDrugs and Chemicals
  • EpinephrineDrugs and Chemicals

All 546 articles in Drugs and Chemicals →

At a glance

1,302
PubMed records on this heading
13%
published since 2020
40
review articles
12
randomized trials
10
verified references below

Counts come from PubMed on 2026-10-31; they show how much has been written, not how strong the evidence is.

Related topics See all →

  • AlbuterolDrugs and Chemicals
  • AtenololDrugs and Chemicals
  • CarvedilolDrugs and Chemicals
  • CholineDrugs and Chemicals
  • EphedrineDrugs and Chemicals

My notes & annotations (0)

Nothing yet. Select text and press Highlight, or write a note in the Notes tab. Stored in this browser only.

Sources

  • NLM MeSH record ↗
  • PubMed search used ↗

EvidenceLib is a research-education resource, not medical advice. It does not diagnose, prescribe or recommend starting, stopping or changing any treatment. Talk to a qualified clinician about your own situation. Methods, sources and licences · Legal · Support